South Dakota Investment Council Regeneron Pharmaceuticals, Inc. Transaction History

South Dakota Investment Council

$5.12 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$700.03 - $830.35 $70,003 - $83,035	-100 Reduced 16.86%	493 $354,000
Q4 2022 Feb 07, 2023	SELL	$705.89 - $766.39 $71,294 - $77,405	-101 Reduced 14.55%	593 $428,000
Q1 2022 May 10, 2022	SELL	$595.12 - $698.43 $196,389 - $230,481	-330 Reduced 32.23%	694 $485,000
Q4 2021 Feb 08, 2022	SELL	$543.48 - $670.97 $434,784 - $536,776	-800 Reduced 43.86%	1,024 $647,000
Q2 2021 Aug 11, 2021	SELL	$472.8 - $558.54 $307,320 - $363,051	-650 Reduced 26.27%	1,824 $1.02 Million
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $227,832 - $279,582	-510 Reduced 17.09%	2,474 $1.17 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $143,490 - $182,394	-300 Reduced 9.14%	2,984 $1.44 Million
Q3 2020 Nov 06, 2020	SELL	$544.75 - $658.21 $490,275 - $592,389	-900 Reduced 21.51%	3,284 $1.84 Million
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $221,994 - $289,764	-450 Reduced 9.71%	4,184 $2.61 Million
Q1 2020 May 11, 2020	SELL	$336.18 - $494.43 $563,437 - $828,664	-1,676 Reduced 26.56%	4,634 $2.26 Million
Q4 2019 Feb 11, 2020	SELL	$274.13 - $376.51 $87,721 - $120,483	-320 Reduced 4.83%	6,310 $2.37 Million
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $131,260 - $152,827	480 Added 7.8%	6,630 $1.84 Million
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $681,590 - $943,715	2,275 Added 58.71%	6,150 $1.93 Million
Q1 2019 May 03, 2019	BUY	$372.08 - $439.57 $74,416 - $87,914	200 Added 5.44%	3,875 $1.59 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $4.76 Million - $5.54 Million	-13,565 Reduced 78.68%	3,675 $1.49 Million
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $3.97 Million - $4.81 Million	13,940 Added 422.42%	17,240 $5.95 Million
Q1 2018 May 10, 2018	BUY	$315.82 - $393.78 $1.04 Million - $1.3 Million	3,300 New	3,300 $1.14 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.

Account